Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation,open-label,non-randomised,uncontrolled, phase 1 trial |
| |
Affiliation: | 1. The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK;2. Institute of Virology, Philipps University of Marburg, Marburg, Germany;3. German Center for Infection Research, Thematic Translational Unit Emerging Infections, Marburg, Germany;4. International Vaccine Institute, Science Unit, Seoul, South Korea |
| |
Abstract: | |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|